Heparin-induced thrombocytopenia diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
m (Categories) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}}; | ||
==Overview== | ==Overview== | ||
Revision as of 19:43, 17 June 2016
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia diagnostic criteria |
|
Heparin-induced thrombocytopenia diagnostic criteria in the news |
|
Blogs on Heparin-induced thrombocytopenia diagnostic criteria |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];